Establishment Labs Holdings (ESTA) Liabilities and Shareholders Equity (2017 - 2026)
Establishment Labs Holdings' quarterly Liabilities and Shareholders Equity came in at $351.0 million in Q1 2026, up 5.3% year-on-year from $333.4 million in Q1 2025, and down 1.72% quarter-over-quarter from $357.2 million in Q4 2025.
Establishment Labs Holdings has reported Liabilities and Shareholders Equity for 10 years, with the latest figure at $351.0 million in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 5.3% year-over-year to $351.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 billion (up 10.32% YoY), and the FY2025 full-year result was $357.2 million, up 2.98% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $351.0 million, down from $357.2 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $357.2 million in Q4 2025, with the low at $141.6 million in Q1 2022.
- Average Liabilities and Shareholders Equity over 5 years is $276.5 million, with a median of $285.1 million recorded in 2024.
- Peak annual rise in Liabilities and Shareholders Equity reached 51.27% in 2022, while the deepest fall reached 7.08% in 2022.
- Tracing ESTA's Liabilities and Shareholders Equity over 5 years: stood at $211.1 million in 2022, then gained by 27.28% to $268.6 million in 2023, then rose by 29.11% to $346.8 million in 2024, then advanced by 2.98% to $357.2 million in 2025, then decreased by 1.72% to $351.0 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $351.0 million (Q1 2026), $357.2 million (Q4 2025), and $338.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn | 351.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 351.04 Mn |
| Dec 31, 2025 | 357.17 Mn |
| Sep 30, 2025 | 338.90 Mn |
| Jun 30, 2025 | 329.67 Mn |
| Mar 31, 2025 | 333.36 Mn |
| Dec 31, 2024 | 346.83 Mn |
| Sep 30, 2024 | 282.69 Mn |
| Jun 30, 2024 | 285.09 Mn |
| Mar 31, 2024 | 301.84 Mn |
| Dec 31, 2023 | 268.64 Mn |
| Sep 30, 2023 | 270.53 Mn |
| Jun 30, 2023 | 285.30 Mn |
| Mar 31, 2023 | 209.36 Mn |
| Dec 31, 2022 | 211.06 Mn |
| Sep 30, 2022 | 187.65 Mn |
| Jun 30, 2022 | 199.88 Mn |
| Mar 31, 2022 | 141.56 Mn |
| Dec 31, 2021 | 139.53 Mn |
| Sep 30, 2021 | 148.36 Mn |
| Jun 30, 2021 | 152.12 Mn |
| Mar 31, 2021 | 152.35 Mn |
| Dec 31, 2020 | 156.39 Mn |
| Sep 30, 2020 | 154.68 Mn |
| Mar 31, 2020 | 168.42 Mn |
| Dec 31, 2019 | 116.53 Mn |
| Sep 30, 2019 | 118.26 Mn |
| Jun 30, 2019 | 104.80 Mn |
| Mar 31, 2019 | 108.96 Mn |
| Dec 31, 2018 | 116.57 Mn |
| Sep 30, 2018 | 121.47 Mn |
| Jun 30, 2018 | 63.32 Mn |
| Dec 31, 2017 | 57.10 Mn |